ADAR1 Capital Management »

Omniab shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Omniab (OABI) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Omniab

Tip: Access up to 7 years of quarterly data

All positions including Omniab held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Omniab by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.4M 452k 5.42
2023-12-31 $3.0M 478k 6.17

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Omniab

Avista Capital Holdings
Henderson Group
BlackRock
BlackRock
Vanguard Group
Macquarie Group
Chicago Capital
Dimensional Fund Advisors
Rubric Capital Management
Rice Hall James & Associates
Geode Capital Management
Private Management Group
State Street Corporation
First Sabrepoint Capital Management
St. Denis J. Villere & Co

View all funds holding Omniab